Concepedia

Hooman Sazegar

HS

Statistics

Publications

7

Citations

2.8K

H-Index

7

Active since

2010

Affiliations

University of California, Los Angeles(Current)

Pfizer (United States)

UCLA Jonsson Comprehensive Cancer Center

Hooman Sazegar is an author at University of California, Los Angeles specializing in cancer research, tumor biology, and radiation oncology.

Top concepts

Publications per year

2010–2013

7

Publications

7

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Ramin Nazarian, Hubing Shi, Qi Wang et al. · Nature · 2010 · 2.1K citations

, , +7

Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032

Jonas Nørskov Søndergaard, Ramin Nazarian, Qi Wang et al. · Journal of Translational Medicine · 2010 · 224 citations · Full text

, , +19

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Rong Huang, Jason Jalil, James S. Economou et al. · Clinical Cancer Research · 2011 · 151 citations · Full text

The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations

Begoña Comı́n-Anduix, Thinle Chodon, Hooman Sazegar et al. · Clinical Cancer Research · 2010 · 139 citations · Full text

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

Franziska Niehr, Erika von Euw, Narsis Attar et al. · Journal of Translational Medicine · 2011 · 96 citations · Full text

1–5 of 7